Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04099966
Recruitment Status : Not yet recruiting
First Posted : September 23, 2019
Last Update Posted : February 27, 2020
Sponsor:
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : December 31, 2023
Estimated Study Completion Date : December 31, 2024